NEUCA S.A.

Warsaw Stock Exchange NEU.WA

NEUCA S.A. Price to Earnings Ratio (P/E) on January 14, 2025: 24.82

NEUCA S.A. Price to Earnings Ratio (P/E) is 24.82 on January 14, 2025, a -4.29% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

NEUCA S.A. 52-week high Price to Earnings Ratio (P/E) is 29.54 on May 24, 2024, which is 19.04% above the current Price to Earnings Ratio (P/E).
NEUCA S.A. 52-week low Price to Earnings Ratio (P/E) is 22.14 on November 19, 2024, which is -10.78% below the current Price to Earnings Ratio (P/E).
NEUCA S.A. average Price to Earnings Ratio (P/E) for the last 52 weeks is 26.04.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Warsaw Stock Exchange: NEU.WA

NEUCA S.A.

CEO	Mr. Piotr Sucharski
IPO Date	Nov. 22, 2004
Location	Poland
Headquarters	ul. Forteczna 35-37
Employees	4,633
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. The company also provides advertising and marketing services; pharmaceutical products under its own brand; clinical trial, telemedicine, agency, financial, road cargo transport, accounting and bookkeeping, software, hospital, and information technology and computer related services; and health, property, and other personal insurance products. In addition, it operates outpatient care clinics and medical stores. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.

Key trends

Past 5 years